News | Breast Imaging | March 14, 2017

Hologic Showcases New Breast Cancer Screening and Interventional Solutions at ECR 2017

Company highlighted Affirm prone breast biopsy system, Lateral Arm accessory for upright biopsy

Hologic, ECR 2017, breast cancer screening solutions, Affirm prone biopsy system

The Affirm prone biopsy system. Image courtesy of Hologic.

March 14, 2017 — Hologic Inc. highlighted its portfolio of innovative breast cancer screening and interventional products, including new solutions for biopsy workflow, at the European Congress of Radiology (ECR) in Vienna, Austria, March 1-5. The company also hosted a symposium and several educational workshops throughout the show, giving attendees opportunities to experience screening and interventional products that offer unique patient and user benefits and address workflow challenges. 

Since its European launch at ECR in 2016, the Affirm prone system — what the company calls the first dedicated prone biopsy system that is upgradable to allow 3-D imaging-guided breast biopsies — has experienced positive clinical and patient feedback, with more than 95 percent of patients indicating in a post-procedure survey that the biopsy experience was faster, more comfortable and less painful than expected. The system provides clinicians with added confidence through high-quality imaging, 2-D and 3-D biopsy capability, faster and easier workflow, and seamless, 360-degree access to the breast.  

In addition to the Affirm prone system, Hologic featured a number of other products at ECR, including:

  • The Affirm upright biopsy system for the Selenia Dimensions mammography system;  
  • The new Affirm Lateral Arm accessory for upright biopsy, to improve access to challenging lesion locations and provide additional patient positioning options;
  • Eviva and ATEC breast biopsy systems, designed to conduct minimally invasive biopsy procedures under stereotactic, tomosynthesis, ultrasound or magnetic resonance imaging (MRI) guidance;
  • I-View software for contrast-enhanced digital mammography provides functional imaging information and highly detailed 2-D images that can be combined with Hologic’s 3-D Mammography exam images; 
  • Low-dose 3-D Mammography exams with C-View software, delivering high-end clinical performance to 2-D mammography for all breast types in a faster, more comfortable and lower dose exam; and
  • The Horizon bone densitometry (DXA) system, a single platform for osteoporosis and body composition testing or assessment.

Hologic held the following events at ECR: 

  • Symposium: A Paradigm Shift in Breast Biopsy Clinical Practice: A European Perspective, featuring Dr. Shirley Go, Dr. Gianfranco Scaperrotta and Dr. Alejandro Tejerina;
  • Eight educational workshops on the use and optimization of clinical practice with 3-D Mammography exams and C-View software, the use of I-View software, and new solutions that optimize VABB workflow and patient comfort 

For more information: www.hologic.com

Related Content

Norwegian Study Confirms Benefits of Pressure-Based Breast Compression for Mammography
News | Mammography | May 22, 2017
Sigmascreening recently announced that a large independent Norwegian study further confirms Sigma’s hypothesis that...
Neiman Institute Releases Breast Screening Bundle Tool
News | Business | May 22, 2017
A new free resource allows radiology practices to estimate professional, technical and global bundled prices for breast...
Seno Medical's Imagio Opto-Acoustic Breast Imaging System Proves Strong Predictor of Malignancy
News | Breast Imaging | May 16, 2017
Seno Medical Instruments Inc. recently announced that is Imagio opto-acoustic (OA/US) breast imaging system results...
Arkansas Surgeon Reports Positive Findings From Use of BioZorb 3-D Marker
News | Radiation Therapy | May 12, 2017
A new research study concluded that use of the BioZorb surgical marker appears to provide better cosmetic outcomes and...
mammography exam

Photo courtesy of Hologic

News | Women's Health | May 11, 2017
Breast cancer is one of the leading causes of death of women worldwide. In Canada, according to the Canadian Cancer...
ABUS

Photo courtesy of GE Healthcare

Feature | Women's Health | May 05, 2017 | By Jeff Zagoudis
Over the last decade, the impact of dense fibroglandular breast tissue on breast cancer screening has become a...
U.S. Clinical Data Supports Echotherapy With Echopulse for Breast Fibroadenomas
News | Focused Ultrasound Therapy | May 04, 2017
Theraclion recently announced the presentation of data from the U.S. feasibility trial of echotherapy with Echopulse, a...
Three-Week Radiation Therapy Treatment Post-Mastectomy Safe and Effective
News | Radiation Therapy | May 02, 2017
A shorter course of radiation therapy given to breast cancer patients following mastectomy is safe and effective and...
Australia's Monash Cancer Centre Treats First Early-Stage Breast Cancer Patient With Xoft System
News | Brachytherapy Systems, Women's Healthcare | May 01, 2017
iCAD Inc. announced the first early-stage breast cancer patient was treated in Australia with intraoperative radiation...
Overlay Init